AK Holdings, Inc. (KRX:006840)
South Korea · Delayed Price · Currency is KRW 11,430
-100 (-0.87%)
At close: Aug 1, 2025, 3:30 PM KST
Intra-Cellular Therapies Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Operating Revenue | 4,245,832 | 4,488,281 | 4,479,660 | 3,787,960 | 3,167,700 | 2,619,977 | Upgrade |
Other Revenue | -0 | -0 | - | -0 | -0 | - | Upgrade |
| 4,245,832 | 4,488,281 | 4,479,660 | 3,787,960 | 3,167,700 | 2,619,977 | Upgrade | |
Revenue Growth (YoY) | -7.11% | 0.19% | 18.26% | 19.58% | 20.91% | -30.31% | Upgrade |
Cost of Revenue | 3,415,916 | 3,522,045 | 3,381,195 | 3,077,497 | 2,661,468 | 2,157,322 | Upgrade |
Gross Profit | 829,915 | 966,235 | 1,098,465 | 710,463 | 506,232 | 462,656 | Upgrade |
Selling, General & Admin | 682,037 | 696,072 | 683,325 | 595,122 | 542,629 | 558,427 | Upgrade |
Research & Development | 24,854 | 24,889 | 25,085 | 22,904 | 18,574 | 19,091 | Upgrade |
Other Operating Expenses | 11,150 | 11,286 | 10,112 | 10,237 | 9,791 | 8,888 | Upgrade |
Operating Expenses | 820,860 | 836,497 | 819,520 | 732,380 | 671,610 | 707,490 | Upgrade |
Operating Income | 9,056 | 129,738 | 278,945 | -21,917 | -165,378 | -244,834 | Upgrade |
Interest Expense | -134,321 | -128,847 | -125,180 | -99,547 | -75,922 | -70,076 | Upgrade |
Interest & Investment Income | 25,169 | 27,467 | 26,921 | 14,059 | 6,930 | 6,624 | Upgrade |
Earnings From Equity Investments | 13,066 | 7,739 | 5,186 | 39,177 | 22,650 | 4,006 | Upgrade |
Currency Exchange Gain (Loss) | -33,470 | -54,706 | 11,909 | -30,813 | -29,612 | 21,731 | Upgrade |
Other Non Operating Income (Expenses) | 46,350 | 12,906 | 25,660 | -5,315 | 4,580 | -22,664 | Upgrade |
EBT Excluding Unusual Items | -74,150 | -5,702 | 223,440 | -104,356 | -236,753 | -305,213 | Upgrade |
Impairment of Goodwill | - | - | -7,789 | -2,797 | - | - | Upgrade |
Gain (Loss) on Sale of Investments | 3,064 | 3,674 | 1,413 | 657.59 | 1,248 | -13,163 | Upgrade |
Gain (Loss) on Sale of Assets | -5,350 | -5,242 | -11,495 | 11,738 | -6,666 | -4,907 | Upgrade |
Asset Writedown | -13,224 | -13,224 | -7,473 | -25,426 | -5,474 | -20,776 | Upgrade |
Pretax Income | -81,985 | -20,493 | 198,096 | -120,183 | -247,644 | -344,060 | Upgrade |
Income Tax Expense | -17,888 | -3,908 | 67,701 | 4,675 | -48,318 | -79,749 | Upgrade |
Earnings From Continuing Operations | -64,096 | -16,586 | 130,395 | -124,858 | -199,326 | -264,311 | Upgrade |
Minority Interest in Earnings | 21,187 | -12,544 | -95,953 | 61,129 | 87,989 | 111,908 | Upgrade |
Net Income | -42,909 | -29,129 | 34,443 | -63,729 | -111,337 | -152,402 | Upgrade |
Net Income to Common | -42,909 | -29,129 | 34,443 | -63,729 | -111,337 | -152,402 | Upgrade |
Shares Outstanding (Basic) | 13 | 13 | 13 | 13 | 13 | 13 | Upgrade |
Shares Outstanding (Diluted) | 13 | 13 | 13 | 13 | 13 | 13 | Upgrade |
Shares Change (YoY) | -0.11% | - | 0.03% | 0.16% | - | - | Upgrade |
EPS (Basic) | -3282.97 | -2228.68 | 2635.21 | -4877.50 | -8534.49 | -11682.38 | Upgrade |
EPS (Diluted) | -3283.00 | -2229.00 | 2635.00 | -4878.00 | -8534.49 | -11682.38 | Upgrade |
Free Cash Flow | -278,881 | -83,189 | 152,977 | 68,184 | -154,441 | -337,969 | Upgrade |
Free Cash Flow Per Share | -21337.18 | -6364.76 | 11704.19 | 5218.45 | -11838.68 | -25906.98 | Upgrade |
Dividend Per Share | 400.000 | 400.000 | 200.000 | 200.000 | 200.000 | 400.000 | Upgrade |
Dividend Growth | 100.00% | 100.00% | - | - | -50.00% | -46.67% | Upgrade |
Gross Margin | 19.55% | 21.53% | 24.52% | 18.76% | 15.98% | 17.66% | Upgrade |
Operating Margin | 0.21% | 2.89% | 6.23% | -0.58% | -5.22% | -9.35% | Upgrade |
Profit Margin | -1.01% | -0.65% | 0.77% | -1.68% | -3.52% | -5.82% | Upgrade |
Free Cash Flow Margin | -6.57% | -1.85% | 3.42% | 1.80% | -4.88% | -12.90% | Upgrade |
EBITDA | 265,292 | 388,293 | 523,687 | 225,815 | 74,094 | 35,231 | Upgrade |
EBITDA Margin | 6.25% | 8.65% | 11.69% | 5.96% | 2.34% | 1.34% | Upgrade |
D&A For EBITDA | 256,236 | 258,555 | 244,741 | 247,732 | 239,472 | 280,065 | Upgrade |
EBIT | 9,056 | 129,738 | 278,945 | -21,917 | -165,378 | -244,834 | Upgrade |
EBIT Margin | 0.21% | 2.89% | 6.23% | -0.58% | -5.22% | -9.35% | Upgrade |
Effective Tax Rate | - | - | 34.18% | - | - | - | Upgrade |
Advertising Expenses | - | 105,298 | 91,556 | 76,461 | 70,573 | 65,432 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.